
B Value
AI Verified
Germany
Venture Capital
BioMedizinZentrum (BMZ), 15, Otto-Hahn-Straße, Studentendorf Dortmund, Eichlinghofen, Hombruch, Dortmund, North Rhine-Westphalia, 44227, Germany
N.A.
Criteria | Requirements | Match |
---|---|---|
Regions | Eastern Europe, Western Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Seed, Series A, Growth Stage, Pre-Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
B Value AG positions itself at the forefront of sustainable innovation, focusing on transformative advancements in biotechnology and advanced materials sectors. The firm strategically invests in technologies that enable environmentally conscious processes and products, recognizing these as foundational elements for future sustainability. Their investment scope encompasses diverse cutting-edge fields including precision fermentation, life science instrumentation, eco-friendly chemical development, and next-generation materials science. Rather than merely following industry trajectories, B Value seeks visionary entrepreneurs developing proprietary technologies with the potential to revolutionize established markets and create entirely new commercial opportunities.
What distinguishes B Value from traditional venture capital firms is their hands-on investment approach powered by a multidisciplinary team with substantial scientific backgrounds, entrepreneurial experience, and venture development expertise. This practical knowledge allows them to provide portfolio companies with guidance that extends far beyond financial support. Their unconventional fund architecture enables exceptional flexibility in investment decisions and facilitates long-term partnerships with portfolio companies, avoiding the typical pressure for premature exits that often characterizes venture capital relationships. B Value positions itself as an active collaborator rather than a passive investor, working alongside founders to transform scientific breakthroughs into commercially viable enterprises.
The firm has cultivated a reputation for identifying and nurturing disruptive technologies with significant market potential. Their portfolio showcases companies developing solutions across the bioeconomy spectrum, from synthetic biology platforms to advanced biomaterials and sustainable chemical processes. B Value typically engages with companies from early development stages through growth phases, providing continuous support throughout the challenging commercialization journey. Their investment thesis centers on backing technologies that not only promise substantial financial returns but also contribute meaningfully to addressing global sustainability challenges.
B Value maintains a global perspective while leveraging strong European connections, particularly within the DACH region's robust scientific and industrial ecosystem. They actively seek partnerships with founders who demonstrate both scientific excellence and commercial acumen, valuing teams that combine technical innovation with market awareness. The firm's investment strategy prioritizes scalable business models built around defensible intellectual property that can create significant competitive advantages. For entrepreneurs developing potentially industry-defining biotechnology or materials science innovations, B Value offers not just capital but a comprehensive partnership designed to navigate the complex journey from laboratory discovery to market leadership.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
B Value maintains its global headquarters in Germany, serving as the strategic center for its operations. The company's primary corporate offices are located at BioMedizinZentrum (BMZ), 15, Otto-Hahn-Straße, Studentendorf Dortmund, Eichlinghofen, Hombruch, Dortmund, North Rhine-Westphalia, 44227, Germany.
B Value focuses its investment activities on companies operating in the following stages: Seed, Series A, Growth Stage, Pre-Seed. B Value provides strategic capital and expertise to support promising businesses at these critical phases of development.
B Value maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Eastern Europe, Western Europe.
B Value was established in , marking the beginning of its journey as an investment firm.
B Value is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.